Cardiac gene delivery in large animal models: Antegrade techniques

Methods in Molecular Biology

Volumn 1521, Issue , 2017, Pages 227-235

  Watanabe, Shin ^a   Leonardson, Lauren ^a   Hajjar, Roger J ^a   Ishikawa, Kiyotake ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Balloon occlusion; Cardiovascular diseases; Gene delivery; Gene therapy; Homogenous distribution; Intracoronary; Minimally invasive; Vectors

Indexed keywords

ANIMAL EXPERIMENT; BALLOON OCCLUSION; CORONARY ARTERY OCCLUSION; CORONARY SINUS; GENE DELIVERY SYSTEM; INTRACORONARY DRUG ADMINISTRATION; INTRACORONARY PERFUSION; NONHUMAN; PERCUTANEOUS ANTEGRADE CORONARY INJECTION; SLOW INTRACORONARY PERFUSION; ANIMAL; ANIMAL MODEL; CARDIAC MUSCLE; CORONARY BLOOD VESSEL; GENE TRANSFER; METABOLISM; PATHOLOGY; PERFUSION; PIG;

ANIMALS; CORONARY VESSELS; GENE TRANSFER TECHNIQUES; MODELS, ANIMAL; MYOCARDIUM; PERFUSION; SUS SCROFA;

EID: 85006013142     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-6588-5_16     Document Type: Chapter

References (16)

1. Logeart D, Hatem SN, Heimburger M, Le Roux A, Michel JB, Mercadier JJ (2001) How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures? Hum Gene Ther 12(13):1601-1610. doi:10.1089/10430340152528101
2. Ishikawa K, Tilemann L, Ladage D, Aguero J, Leonardson L, Fish K, Kawase Y (2012) Cardiac gene therapy in large animals: bridge from bench to bedside. Gene Ther 19(6):670-677. doi:10.1038/gt.2012.3
3. Donahue JK, Kikkawa K, Johns DC, Marban E, Lawrence JH (1997) Ultrarapid, highly effi-cient viral gene transfer to the heart. Proc Natl Acad Sci U S A 94(9):4664-4668
4. Emani SM, Shah AS, Bowman MK, Emani S, Wilson K, Glower DD, Koch WJ (2003) Catheter-based intracoronary myocardial adenoviral gene delivery: importance of intraluminal seal and infusion flow rate. Mol Ther 8(2):306-313
5. Hajjar RJ, Schmidt U, Matsui T, Guerrero JL, Lee KH, Gwathmey JK, Dec GW, Semigran MJ, Rosenzweig A (1998) Modulation of ventricular function through gene transfer in vivo. Proc Natl Acad Sci U S A 95(9):5251-5256
6. Ishikawa K, Aguero J, Naim C, Fish K, Hajjar RJ (2013) Percutaneous approaches for effi-cient cardiac gene delivery. J Cardiovasc Transl Res 6(4):649-659. doi:10.1007/s12265-013-9479-7
7. Kawase Y, Ly HQ, Prunier F, Lebeche D, Shi Y, Jin H, Hadri L, Yoneyama R, Hoshino K, Takewa Y, Sakata S, Peluso R, Zsebo K, Gwathmey JK, Tardif JC, Tanguay JF, Hajjar RJ (2008) Reversal of cardiac dysfunction after long-term expression of SERCA2a by gene transfer in a pre-clinical model of heart failure. J Am Coll Cardiol 51(11):1112-1119. doi:10.1016/j.jacc.2007.12.014
8. Tilemann L, Lee A, Ishikawa K, Aguero J, Rapti K, Santos-Gallego C, Kohlbrenner E, Fish KM, Kho C, Hajjar RJ (2013) SUMO-1 gene transfer improves cardiac function in a large-animal model of heart failure. Sci Transl Med 5(211):211ra159. doi:10.1126/scitranslmed.3006487
9. Ishikawa K, Fish KM, Tilemann L, Rapti K, Aguero J, Santos-Gallego CG, Lee A, Karakikes I, Xie C, Akar FG, Shimada YJ, Gwathmey JK, Asokan A, McPhee S, Samulski J, Samulski RJ, Sigg DC, Weber T, Kranias EG, Hajjar RJ (2014) Cardiac I-1c overexpression with reengineered AAV improves cardiac function in swine ischemic heart failure. Mol Ther 22(12):2038-2045. doi:10.1038/mt.2014.127
10. Fish KM, Ladage D, Kawase Y, Karakikes I, Jeong D, Ly H, Ishikawa K, Hadri L, Tilemann L, Muller-Ehmsen J, Samulski RJ, Kranias EG, Hajjar RJ (2013) AAV9.I-1c delivered via direct coronary infusion in a porcine model of heart failure improves contractility and mitigates adverse remodeling. Circ Heart Fail 6(2):310-317. doi:10.1161/CIRCHEARTFAILURE.112.971325
11. Greenberg B, Yaroshinsky A, Zsebo KM, Butler J, Felker GM, Voors AA, Rudy JJ, Wagner K, Hajjar RJ (2014) Design of a phase 2b trial of intracoronary administration of AAV1/SERCA2a in patients with advanced heart failure: the CUPID 2 trial (calcium upregulation by percutaneous administration of gene therapy in cardiac disease phase 2b). JACC Heart Fail 2(1):84-92. doi:10.1016/j.jchf.2013.09.008
12. Ishikawa K, Ladage D, Tilemann L, Fish K, Kawase Y, Hajjar RJ (2011) Gene transfer for ischemic heart failure in a preclinical model. J Vis Exp (51). doi:10.3791/2778
13. Hayase M, Del Monte F, Kawase Y, Macneill BD, McGregor J, Yoneyama R, Hoshino K, Tsuji T, De Grand AM, Gwathmey JK, Frangioni JV, Hajjar RJ (2005) Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade. Am J Physiol Heart Circ Physiol 288(6):H2995-H3000. doi:10.1152/ajpheart.00703.2004
14. Boekstegers P, von Degenfeld G, Giehrl W, Heinrich D, Hullin R, Kupatt C, Steinbeck G, Baretton G, Middeler G, Katus H, Franz WM (2000) Myocardial gene transfer by selective pressure-regulated retroinfusion of coronary veins. Gene Ther 7(3):232-240. doi:10.1038/sj.gt.3301079
15. Shah AS, White DC, Emani S, Kypson AP, Lilly RE, Wilson K, Glower DD, Lefkowitz RJ, Koch WJ (2001) In vivo ventricular gene delivery of a beta-adrenergic receptor kinase inhibitor to the failing heart reverses cardiac dysfunction. Circulation 103(9):1311-1316
16. Wright MJ, Wightman LM, Latchman DS, Marber MS (2001) In vivo myocardial gene transfer: optimization and evaluation of intracoronary gene delivery in vivo. Gene Ther 8(24):1833-1839. doi:10.1038/sj.gt.3301614